A

    Adobe Systems Incorporated (ADBE)

    Official site

    TECHNOLOGY • SOFTWARE - APPLICATION • NASDAQ

    $292.79
    +1.27 (+0.44%)

    Market Cap: $116.38B

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    97%(38/39)
    Avg Surprise
    +4.03%
    Streak
    30 Q

    Upcoming Estimates

    Period ending Aug 31, 2026
    EPS Consensus$6.08
    Range$5.82 - $6.35
    29 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$5.77-5.1%
    60d ago$6.08+0.0%
    30d ago$6.08+0.0%
    7d ago$6.08+0.0%
    Current$6.08
    Revenue Consensus
    $6.7B
    Range$6.6B - $6.8B
    27 analysts
    Period ending Nov 30, 2026
    EPS Consensus$6.65
    Range$6.33 - $7.22
    34 analysts
    Revenue Consensus
    $7.1B
    Range$6.4B - $7.3B
    33 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Nov 26EST
    -$6.65---
    Aug 26EST
    -$6.08---
    May 26
    Reported Jun 11
    $5.96$5.81+2.58%Beat+17.8%
    Feb 26
    Reported Mar 12
    $6.06$5.87+3.24%Beat+41.6%
    Nov 25
    Reported Dec 10
    $5.50$5.40+1.85%Beat+14.3%
    Aug 25
    Reported Sep 11
    $5.31$5.18+2.51%Beat+14.2%
    May 25
    Reported Jun 12
    $5.06$4.97+1.81%Beat+12.9%
    Feb 25
    Reported Mar 12
    $4.28$4.07+5.16%Beat-4.5%
    Nov 24
    Reported Dec 11
    $4.81$4.67+3.00%Beat+12.6%
    Aug 24
    Reported Sep 12
    $4.65$4.54+2.42%Beat+13.4%
    May 24
    Reported Jun 13
    $4.48$4.40+1.82%Beat+14.6%
    Feb 24
    Reported Mar 14
    $4.48$4.38+2.28%Beat+17.9%
    Nov 23
    Reported Dec 13
    $4.27$4.14+3.14%Beat+18.6%
    Aug 23
    Reported Sep 14
    $4.10$3.98+3.02%Beat+20.6%
    May 23
    Reported Jun 15
    $3.91$3.79+3.17%Beat+16.7%
    Feb 23
    Reported Mar 15
    $3.80$3.68+3.26%Beat+12.8%
    Nov 22
    Reported Dec 15
    $3.60$3.50+2.86%Beat+12.5%
    Aug 22
    Reported Sep 15
    $3.40$3.34+1.80%Beat+9.3%
    May 22
    Reported Jun 16
    $3.35$3.31+1.21%Beat+10.6%
    Feb 22
    Reported Mar 22
    $3.37$3.34+0.90%Beat+7.3%
    Nov 21
    Reported Dec 16
    $3.20$3.20+0.00%Beat+13.9%
    Aug 21
    Reported Sep 21
    $3.11$3.02+2.98%Beat+21.0%
    May 21
    Reported Jun 17
    $3.03$2.82+7.45%Beat+23.7%
    Feb 21
    Reported Mar 23
    $3.14$2.79+12.54%Beat+38.3%
    Nov 20
    Reported Dec 10
    $2.81$2.66+5.64%Beat+22.7%
    Aug 20
    Reported Sep 15
    $2.57$2.41+6.64%Beat+25.4%
    May 20
    Reported Jun 11
    $2.45$2.32+5.60%Beat+33.9%
    Feb 20
    Reported Mar 12
    $2.27$2.23+1.79%Beat+32.7%
    Nov 19
    Reported Dec 12
    $2.29$2.26+1.33%Beat+25.1%
    Aug 19
    Reported Sep 17
    $2.05$1.97+4.06%Beat+18.5%
    May 19
    Reported Jun 18
    $1.83$1.78+2.81%Beat+10.2%
    Feb 19
    Reported Mar 14
    $1.71$1.62+5.56%Beat+10.3%
    Nov 18
    Reported Dec 13
    $1.83$1.84-0.54%Miss+45.2%
    Aug 18
    Reported Sep 13
    $1.73$1.69+2.37%Beat+57.3%
    May 18
    Reported Jun 14
    $1.66$1.54+7.79%Beat+62.7%
    Feb 18
    Reported Mar 15
    $1.55$1.44+7.64%Beat+64.9%
    Nov 17
    Reported Dec 14
    $1.26$1.16+8.62%Beat+40.0%
    Aug 17
    Reported Sep 19
    $1.10$1.01+8.91%Beat-
    May 17
    Reported Jun 20
    $1.02$0.95+7.37%Beat-
    Feb 17
    Reported Mar 16
    $0.94$0.87+8.05%Beat-
    Nov 16
    Reported Dec 15
    $0.90$0.86+4.65%Beat-

    Dividends

    Dividend Metrics

    Yield0.00%
    Annual/Share$0.00
    Payout Ratio0.00%
    No dividend payments in the selected period.
    View ADBE's full dividend history

    Key Metrics

    Valuation
    P/E Ratio12.82EV/EBITDA11.49x
    Price/FCF11.46xFCF Yield8.73%
    Profitability
    Profit Margin28.70%Operating Margin35.30%
    ROE62.90%ROIC40.21%
    Financial Health
    Debt/Equity0.58xInterest Coverage34.05x
    Current Ratio0.75xQuick Ratio0.75x
    Trading Statistics
    Beta1.40Avg Volume4.29M
    52-Week High$370.8652-Week Low$190.12

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$278.02
    SMA 20$270.32
    SMA 50$242.13
    SMA 200$268.98
    EMA 10$279.65
    EMA 20$270.17
    EMA 50$254.42
    EMA 200$271.47

    MACD

    Line: 12.01Signal: 10.60Hist: 1.41

    ADX

    ADX: 26.0+DI: 34.9-DI: 16.6

    Aroon & PSAR

    Aroon Up100.0
    Aroon DownN/A
    PSAR$266.70

    Bollinger Bands

    Upper Band$292.59
    Lower Band$248.06
    %B Position1647%(Upper)
    Band Width1.00

    RSI (14-Day)

    Neutral
    69.3

    Momentum Oscillators

    Stoch %K95.3
    Stoch %D90.2
    Williams %R-3.1
    ROC (10d)15.3%
    Momentum38.75
    CCI (20d)179.1
    MFI (14d)75.7

    Volatility Measures

    ATR (14d)$10.45(3.6%)
    StdDev (20d)11.13
    Hist Vol40.4%(High)

    Volume Flow

    VWAP$291.06
    OBV-70.8M
    AD Line2.3M
    CMF (20d)0.333

    Volume Metrics

    Avg Vol (20d)4.3M
    Vol Ratio1.2x
    VWMA (20d)$270.80

    Pivot Points

    R3$302.46
    R2$298.28
    R1$294.90
    Pivot Point$290.71
    S1$287.33
    S2$283.14
    S3$279.76

    Advanced Oscillators

    TSI27.97
    Ultimate Osc72.3
    KST164.19

    Financial Data

    QuarterMay 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024Aug 2024May 2024Feb 2024Nov 2023Aug 2023
    Total Revenue$6.62B$6.40B$6.19B$5.99B$5.87B$5.71B$5.61B$5.41B$5.31B$5.18B$5.05B$4.89B
    Cost of Revenue$715.00M$664.00M$649.00M$642.00M$638.00M$622.00M$616.00M$554.00M$598.00M$590.00M$634.00M$580.00M
    Gross Profit$5.90B$5.73B$5.54B$5.35B$5.24B$5.09B$4.99B$4.85B$4.71B$4.59B$4.41B$4.31B
    Operating Expenses$3.67B$3.32B$3.28B$3.17B$3.13B$2.93B$3.03B$2.86B$2.83B$3.69B$2.67B$2.61B
    R&D$1.20B$1.11B$1.10B$1.09B$1.08B$1.03B$999.00M$1.02B$984.00M$939.00M$889.00M$881.00M
    SG&A$546.00M$463.00M$421.00M$408.00M$377.00M$367.00M$456.00M$366.00M$355.00M$352.00M$372.00M$353.00M
    Operating Income$2.24B$2.42B$2.26B$2.17B$2.11B$2.16B$1.96B$1.99B$1.89B$907.00M$1.74B$1.70B
    Interest Income$18.00M$5.00M$12.00M$23.00M$2.00M$6.00M$14.00M$12.00M$4.00M$18.00M$4.00M$6.00M
    Interest Expense$0$0$66.00M$67.00M$8.00M$0$50.00M$51.00M$41.00M$27.00M$28.00M$27.00M
    Income Before Tax$2.24B$2.42B$2.26B$2.19B$2.10B$2.18B$1.99B$2.04B$1.93B$968.00M$1.81B$1.74B
    Income Tax Expense$526.00M$533.00M$408.00M$415.00M$410.00M$371.00M$308.00M$358.00M$357.00M$348.00M$325.00M$340.00M
    Net Income$1.71B$1.89B$1.86B$1.77B$1.69B$1.81B$1.68B$1.68B$1.57B$620.00M$1.48B$1.40B
    EBITDA$2.43B$2.59B$2.50B$2.44B$2.32B$2.38B$2.25B$2.29B$2.18B$1.19B$2.05B$1.98B
    EBIT$2.24B$2.42B$2.32B$2.23B$2.11B$2.16B$2.03B$2.08B$1.97B$977.00M$1.83B$1.76B
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    Veeva (VEEV): A Record-Keeper Whose Own Books Are Under Audit

    Veeva is the regulated life-sciences system of record, owning narrow workflows with high switching costs, layering AI agents across core apps, and focusing on industry penetration not broad enterprise competition Fiscal Q1 revenue $882.9M up 16% YoY, subscription revenue $730.2M up 15%, non-GAAP EPS $2.24, GAAP net income $260.9M up 14%, management raised FY27 revenue to $3.635-3.645B and EPS to about $9.05 Operating quality and balance sheet strength are high - gross margin 75.0%, operating margin 30.9%, net margin 28.4%, net cash ~$1.88B, current ratio 4.74, Altman Z >11, Beneish M-score -2.62, Market repricing created an opening - stock down ~45% TTM and ~48% below 52-week high $310.50, trading at 17.7x forward EPS and 0.72 PEG, Wall Street target $245.48 Skepticism centers on stock-based compensation - Q1 SBC $119.3M annualized ~$477M, Veeva remains GAAP profitable and survives the compensation-adjusted cash flow test better than many peers

    Unknown Author
    6/17/26
    171
    Life Sciences Software
    Quality Compounder
    Also mentions:
    CRM
    ADBE

    When Wall Street Indicts a Cash Flow Machine: Reading CRM Before the May 27 Earnings

    Market punished CRM - 41% off 52-week high, ~24% below 200-day - yet trailing 12-month free cash flow was $14.4B on $41.5B revenue, FCF margin 34.7% and cash conversion ~96% Execution metrics support resilience - 3-yr FCF CAGR 31.6%, 5-yr revenue CAGR 14.3%, 3-yr EPS CAGR 26%, last 8 quarters 88% beat rate, avg surprise 7.6% Shareholder-friendly capital allocation - dividend raised to $0.44, $25B buyback authorized, net debt $7.1B vs $14.4B FCF, net leverage <0.6x EBITDA, interest coverage 45x Company is buying into AI not ceding ground - $300M Anthropic spend planned, agent platform ARR $800M (+169% YoY), 2.4B agent work units last quarter (+57% seq), $8B data integration deal closed

    Unknown Author
    5/18/26
    269
    Enterprise Software
    Also mentions:
    ADBE
    NOW
    ORCL

    When Martech Meets OpenAI: The Zeta Global Operating Leverage Play

    OpenAI partnership at CES '26 validates AI strategy, but profitability crossover is the real catalyst worth watching for multiple expansion EBITDA margin hit 23.2% in Q3, extending 19-quarter streak; operating leverage converting growth into bankable profits GNG rates Ultra Value Buy at 51% discount to $42.99 fair value; Stock Rover more conservative at ~$26, highlighting thesis risk Altman Z-Score 6.47 (Safe zone) combined with 0.29 D/E and net cash position removes near-term distress concern Entry at $20.19 is below Ultra Value threshold ($21.82); invalidation level adjusted to $18.50 sustained breakdown Athena AI agent launching Q1 2026 could accelerate enterprise stickiness; TKO early access shows productivity gains

    Unknown Author
    1/27/26
    330
    MarTech
    growth-stocks
    Also mentions:
    CRM
    ADBE
    PATH

    5 Buy Opportunities: GNG Research Terminal + 52-Week Low Contrarian Screen

    Screened 5,500+ stocks through GNG Research Terminal's Ultra Value Buy ranking and 52-week low contrarian overlay. Only 5 passed both tests: LRN, DDI, PFE from Ultra Value screen; ADBE, NVO from 52-week low with strong V DDI trades at $8.90 with $9.50/share in net cash. You're getting the operating business for free. 39% operating margins, 32% FCF yield, and European iGaming expansion grew 108% last quarter. ADBE at 14x forward earnings is the cheapest since early 2010s. Still delivering 36% operating margins, 41% FCF margins, and 11% growth. Market overreacted to Figma/Canva fears while Adobe monetizes AI through Firefly. LRN offers 8x P/E on 18% revenue growth. Career Learning segment up 60%+. Net cash balance sheet enabled $500M buyback. Classic post-COVID mispricing in online education. PFE yields 6.75%+ at 13x forward earnings. Pipeline includes oral obesity drugs, $43B Seagen oncology portfolio, RSV vaccines. Management targets $25B new product revenue by 2030. Get paid to wait for execution. NVO dropped 45% from peak but still growing 29% with 42% operating margins. Profit warning was about investing in supply because demand outstrips capacity. Selloff

    Unknown Author
    1/11/26
    992
    Research Terminal
    Ultra Value Buy
    Systematic Screening
    Also mentions:
    ADBE
    DDI
    LRN
    PFE

    Adobe: A Coiled Spring Set To Soar Or A Value Trap To Ignore? (ZEUS Portfolio Candidate Analysis)

    Financial Consensus: FactSet projects revenue reaching $36.3 billion by 2030 with $32.20 EPS. This steady 9-12% growth confirms Adobe is a reliable "Compounder," not a volatile hype stock. The "Safe AI" Moat: Unlike competitors facing copyright lawsuits, Adobe’s Firefly is trained on owned images. This makes it the only "commercially safe" option for Fortune 500s avoiding legal risks. Strategic Pivot: By linking creative tools with marketing data into a "Content Supply Chain," Adobe secures massive contracts from CEOs needing to create, manage, and measure content efficiently. Defensive Edge: Morningstar assigns a "Wide Moat" due to high switching costs. With the industry standardized on Adobe files (.PSD, .PDF), professionals cannot switch tools without breaking workflows. Expanding the Funnel: To fight Canva, Adobe launched the web-based Express app. This creates a "farm system," capturing casual users early who eventually upgrade to professional tools. Valuation Opportunity: Trading at $339 against a $560 to $597 Fair Value (39% to 42% discount), the market’s irrational fear of AI displacement offers investors a significant "margin of safety." The "Seat" Risk: The main risk is "Seat Compression" if AI reduces designer headcounts. Adobe must successfully monetize AI usage via Generative Credits to offset potential license losses. Base-case 26% CAGR return over the next 3 years (100% upside by 2028) with potentially 3X in 3 years if Adobe's growth rates accelerate to historical levels. ZEUS would buy except for our cash constraints.

    Unknown Author
    12/10/25
    365
    AI Infrastructure
    growth-stocks
    PEGY Ratio
    High ROIC

    Government Contracts

    Gov Obligations (TTM)
    $0
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    1
    New Awards (TTM)
    1
    Avg Remaining Term
    1.5 mo

    Recent Awards

    Award IDAgencyObligatedStart
    95170025M0129U.S. Agency for Global MediaU.S. Agency for Global Media$22546Sep 29, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Frequently Asked Questions About ADBE

    Does ADBE pay dividends?
    Adobe Systems Incorporated (ADBE) has a dividend payment track record. See the ADBE dividend history page for its current payment status, yield, and streaks.
    What is ADBE's P/E ratio?
    Adobe Systems Incorporated has a price-to-earnings (P/E) ratio of 12.82.
    What is ADBE's market cap?
    Adobe Systems Incorporated (ADBE) has a market capitalization of $116.38B with a current stock price of $292.79.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.